Who is the CEO of Ensol Biosciences?

According to the DART company overview, Ensol Biosciences' representative director is 김해진 (name as registered in Korean). The company was founded on 2001-02-20.

Where is Ensol Biosciences listed?

Ensol Biosciences trades on the Korea Exchange KONEX market under the ticker 140610. Its fiscal year ends in December.

Does Ensol Biosciences pay a dividend?

Ensol Biosciences did not pay a cash dividend for fiscal 2025, according to its annual report.

Which companies are in the same industry as Ensol Biosciences?

Under the Korean Standard Industrial Classification recorded on DART, Ensol Biosciences is grouped with 53 other listed companies in medical & pharmaceutical r&d. The most covered in Korean news over the past 30 days are Alteogen, D&D Pharmatech and LigaChem Biosciences.

Ensol Biosciences KRX:140610KONEX

엔솔바이오사이언스 · Korean news coverage and regulatory filings, organized.

한국어

Articles, 24h0

Articles, 7 days0

DART filings, 7 days0

Articles tracked0since Sep 11

Ensol Biosciences (엔솔바이오사이언스) appeared in 0 Korean news articles and 0 DART filings over the past seven days.

Ensol Biosciences top stories 2 weeks, by number of outlets

No story covered by multiple outlets in the past two weeks.

Latest Ensol Biosciences news Korean headlines

No articles yet.

Articles per day 2 weeks

Company profile

CEO: 김해진
Industry: Medical & pharmaceutical R&D
Founded: 2001-02-20
Fiscal year-end: December
Head office: 대전광역시 유성구
Website: ensolbio.co.kr
Quotes & chart: Naver Securities (Korean)

From the DART company overview.

Same industry Medical & pharmaceutical R&D

All in industry

Company	Latest quarter op. profit	Articles 30d
Alteogen	–	256
D&D Pharmatech	−₩13.6bn	72
LigaChem Biosciences	−₩50.4bn	69
Curocell	−₩7.7bn	51
SillaJen	–	44
OliX Pharmaceuticals	–	42
Qurient	−₩7.0bn	41
GI Innovation	–	41

Compare Ensol Biosciences side by side with these companies

Ensol Biosciences DART filings

Oct 2117:09

Corporate briefing (IR) held
Other

Mentioned alongside 2 weeks

No co-mentioned companies yet.

Ensol Biosciences FAQ

Who is the CEO of Ensol Biosciences?: According to the DART company overview, Ensol Biosciences' representative director is 김해진 (name as registered in Korean). The company was founded on 2001-02-20.
Where is Ensol Biosciences listed?: Ensol Biosciences trades on the Korea Exchange KONEX market under the ticker 140610. Its fiscal year ends in December.
Does Ensol Biosciences pay a dividend?: Ensol Biosciences did not pay a cash dividend for fiscal 2025, according to its annual report.
Which companies are in the same industry as Ensol Biosciences?: Under the Korean Standard Industrial Classification recorded on DART, Ensol Biosciences is grouped with 53 other listed companies in medical & pharmaceutical r&d. The most covered in Korean news over the past 30 days are Alteogen, D&D Pharmatech and LigaChem Biosciences.